IsoPlexis

IsoPlexis

IsoPlexis

IsoPlexis, a venturebacked Yalespinout company, is developing a diagnostic platform to accelerate immunology research and therapeutic development.
Type
B2c
Founded
2012
Raised
$44.3M
Follow us
Alexa global traffic share
Team Size
10+
Employees
TechCrunch

IsoPlexis, a company uncovering a ‘new layer’ of cell data, aims for $125M in market debut

$25,000,000 Venture capital (Series C)
PE HUB

IsoPlexis rallies $25 mln Series C

FinSMEs

IsoPlexis Closes $25M Series C Financing

$13,500,000 Venture capital (Series B)
PE HUB

IsoPlexis Corp snags $13.5 mln Series B